Wird geladen...
A Phase 2 Study of a Non-myeloablative Allogeneic Stem Cell Transplant with Peri-transplant Rituximab in Patients with B-cell Lymphoid Malignancies: Favorably Durable Event-free Survival in Chemosensitive Patients
The aim of this prospective phase II trial was to determine the safety and efficacy of a nonmyeloablative (NMA) conditioning program incorporating peri-transplant-rituximab in patients with CD20+ B-cell non-Hodgkin lymphoma (B-NHL) receiving an allogeneic stem cell transplant (allo-SCT). Fifty-one a...
Gespeichert in:
| Veröffentlicht in: | Biol Blood Marrow Transplant |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4374345/ https://ncbi.nlm.nih.gov/pubmed/24315843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.11.029 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|